Figure 7
From: SLC25A11 serves as a novel prognostic biomarker in liver cancer

Cox model of RFS among liver cancer patients. Univariate and multivariate analysis of the correlation of SLC25A11 expression with RFS among liver cancer patients.
From: SLC25A11 serves as a novel prognostic biomarker in liver cancer

Cox model of RFS among liver cancer patients. Univariate and multivariate analysis of the correlation of SLC25A11 expression with RFS among liver cancer patients.